Skip to main content
. 2022 Jul 9;10(7):1654. doi: 10.3390/biomedicines10071654

Figure 4.

Figure 4

Impacts of quercetin-loaded nanoparticles (QT-NPs) therapy on fecal calprotectin levels post DSS induction. Control: healthy non-colitic group: (rats orally gavaged with PBS); Colitic groups: DSS (rats orally gavaged with dextran sodium sulphate), DSS + QT-NPsI (rats orally gavaged with DSS and quercetin-loaded nanoparticles (QT-NPs at the level 10 mg/kg body weight for 14 days)), DSS + QT-NPsII (rats orally gavaged with DSS and quercetin-loaded nanoparticles (QT-NPs at the level 15 mg/kg body weight for 14 days)), and DSS + QT-NPsIII (rats orally gavaged with DSS and quercetin-loaded nanoparticles (QT-NPs at the level 20 mg/kg body weight for 14 days)). All groups orally gavaged by 3% DSS.